EP
NAMS icon

Eversept Partners’s NewAmsterdam Pharma NAMS Stock Holding History

Eversept Partners’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.15M Sell
285,764
-135,063
-32% -$4.4M 0.6% 46
2025
Q4 		$14.8M Sell
420,827
-67,765
-14% -$2.47M 0.83% 34
2025
Q3 		$13.9M Buy
488,592
+74,162
+18% +$1.78M 1.06% 27
2025
Q2 		$7.51M Buy
414,430
+133,479
+48% +$2.43M 0.76% 35
2025
Q1 		$5.75M Buy
280,951
+5,589
+2% +$124K 0.65% 34
2024
Q4 		$7.08M Sell
275,362
-31,995
-10% -$680K 0.73% 33
2024
Q3 		$5.1M Sell
307,357
-22,533
-7% -$390K 0.39% 37
2024
Q2 		$6.34M Sell
329,890
-24,075
-7% -$483K 0.49% 39
2024
Q1 		$8.37M Sell
353,965
-20,439
-5% -$415K 0.63% 32
2023
Q4 		$4.18M Sell
374,404
-286,214
-43% -$2.62M 0.41% 42
2023
Q3 		$6.11M Sell
660,618
-31,751
-5% -$344K 0.68% 35
2023
Q2 		$8.23M Buy
692,369
+646,513
+1,410% +$8.58M 0.87% 32
2023
Q1 		$608K Buy
+45,856
New +$579K 0.05% 61

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DFO
Duquesne Family Office New York $2.94B AUM 61.92% 1-Year Est. Return